Ignite Creation Date:
2024-05-06 @ 7:25 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02533050
Status:
TERMINATED
Last Update Posted:
2019-01-29
First Post:
2015-08-24
Brief Title:
Attentional Capacity and Working Memory in Coronary Artery Disease Patients Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Organization:
Centre Hospitalier Universitaire de Saint Etienne
Study Overview
Official Title:
Attentional Capacity and Working Memory in Coronary Artery Disease Patients Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With a Continuous Positive Airway Pressure System CPAP Etude CAPCORSAS
Status:
TERMINATED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of inclusion
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPCORSAS
Brief Summary:
The presence of Obstructive Sleep Apnea Syndrome OSAS has a high frequency in patients victims of a coronary artery disease CAD myocardial infarction revascularization Unlike patients seen in a sleep Laboratory with an impact on daytime functioning CAD apneic patients do not complain in their daytime functioning The objective of this study is to explore whether the objective cognitive assessment measures may be a good marker of the efficacy of CPAP treatment given to non-sleepy apneic CAD patients
Coronary patients with an AHI between 15 and 40 h will be treated or not after randomization with CPAP treatment The expected results are CPAP apneic coronary patients should have a positive impact on cognitive performance particularly on attention span and working memory measured by improvement in the Paced Auditory Serial Addition Test score PASAT score
Coronary patients with an AHI between 15 and 40 h will be treated or not after randomization with CPAP treatment The expected results are CPAP apneic coronary patients should have a positive impact on cognitive performance particularly on attention span and working memory measured by improvement in the Paced Auditory Serial Addition Test score PASAT score
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2013-A01635-40 | OTHER | ANSM | None |